Distinct roles for nitric oxide in resistant C57BL/6 and susceptible BALB/c mice to control Burkholderia pseudomallei infection

BMC Immunology

Volumn 12, Issue , 2011, Pages

  Breitbach, Katrin ^a   Wongprompitak, Patimaporn ^a,b   Steinmetz, Ivo ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMMINOGUANIDINE; GAMMA INTERFERON; GUANIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL LOAD; BURKHOLDERIA PSEUDOMALLEI; CELL GROWTH; CONTROLLED STUDY; DISEASE PREDISPOSITION; LIVER; MACROPHAGE; MELIOIDOSIS; MORTALITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT INFECTION; SPLEEN; STRAIN DIFFERENCE; SURVIVAL RATE; TOXOPLASMOSIS; WILD TYPE; ACTIVE IMMUNIZATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CYTOTOXICITY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; MOUSE MUTANT; PATHOGENICITY; SPECIES DIFFERENCE;

ANIMALS; BURKHOLDERIA PSEUDOMALLEI; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; GUANIDINE; HUMANS; IMMUNITY, ACTIVE; MACROPHAGE ACTIVATION; MELIOIDOSIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SPECIES SPECIFICITY;

EID: 79952705005     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-12-20     Document Type: Article

References (19)

1. Nahrevanian H. Involvement of nitric oxide and its up/down stream molecules in the immunity against parasitic infections. Braz J Infect Dis 2009, 13:440-8.
2. Yang CS, Yuk JM, Jo EK. The role of nitric oxide in mycobacterial infections. Immune Netw 2009, 9:46-52. 10.4110/in.2009.9.2.46, 2803309, 20107543.
3. Costa VM, Torres KC, Mendonca RZ, Gresser I, Gollob KJ, Abrahamsohn IA. Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection. J Immunol 2006, 177:3193-200.
4. Huang J, DeGraves FJ, Lenz SD, Gao D, Feng P, D L, Schlapp T, Kaltenboeck B. The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease. Proc Natl Acad Sci USA 2002, 99:3914-9. 10.1073/pnas.062578399, 122623, 11904441.
5. Vazquez-Torres A, Jones-Carson J, Mastroeni P, Ischiropoulos H, Fang FC. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J Exp Med 2000, 192:227-36. 10.1084/jem.192.2.227, 2193262, 10899909.
6. Khan IA, Schwartzman JD, Matsuura T, Kasper LH. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc Natl Acad Sci USA 1997, 94:13955-60. 10.1073/pnas.94.25.13955, 28414, 9391134.
7. Schluter D, Deckert-Schluter M, Lorenz E, Meyer T, Rollinghoff M, Bogdan C. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice. J Immunol 1999, 162:3512-8.
8. Saeftel M, Fleischer B, Hoerauf A. Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infect Immun 2001, 69:2252-9. 10.1128/IAI.69.4.2252-2259.2001, 98153, 11254581.
9. Kang KM, Lee GS, Lee JH, Choi IW, Shin DW, Lee YH. Effects of iNOS inhibitor on IFN-gamma production and apoptosis of splenocytes in genetically different strains of mice infected with Toxoplasma gondii. Korean J Parasitol 2004, 42:175-83. 10.3347/kjp.2004.42.4.175, 2717383, 15591835.
10. White NJ. Melioidosis. Lancet 2003, 361:1715-22. 10.1016/S0140-6736(03)13374-0, 12767750.
11. Dance DA. Melioidosis. Curr Opin Infect Dis 2002, 15:127-32.
12. Leelarasamee A, Bovornkitti S. Melioidosis: review and update. Rev Infect Dis 1989, 11:413-25. 10.1093/clinids/11.3.413, 2665001.
13. Hoppe I, Brenneke B, Rohde M, Kreft A, Haussler S, Reganzerowski A, Steinmetz I. Characterization of a murine model of melioidosis: comparison of different strains of mice. Infect Immun 1999, 67:2891-900. 96597, 10338496.
14. Liu B, Koo GC, Yap EH, Chua KL, Gan YH. Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun 2002, 70:504-11. 10.1128/IAI.70.2.504-511.2002, 127661, 11796576.
15. Leakey AK, Ulett GC, Hirst RG. BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis. Microb Pathog 1998, 24:269-75. 10.1006/mpat.1997.0179, 9600859.
16. Breitbach K, Klocke S, Tschernig T, van Rooijen N, Baumann U, Steinmetz I. Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect Immun 2006, 74:6300-9. 10.1128/IAI.00966-06, 1695503, 17000727.
17. Adler H, Beland JL, Del-Pan NC, Kobzik L, Brewer JP, Martin TR, Rimm IJ. Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J Exp Med 1997, 185:1533-40. 10.1084/jem.185.9.1533, 2196291, 9151890.
18. MacFarlane AS, Schwacha MG, Eisenstein TK. In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen. Infect Immun 1999, 67:891-8. 96401, 9916105.
19. Eske K, Breitbach K, Kohler J, Wongprompitak P, Steinmetz I. Generation of murine bone marrow derived macrophages in a standardised serum-free cell culture system. J Immunol Methods 2009, 342:13-9. 10.1016/j.jim.2008.11.011, 19133267.